“…In one of these studies carried out by Gunduz et al [9], a retrospective pilot study encompassing 22 chronic coccydynia patients on whom ganglion impar blockade was conducted via the transsacrococcygeal pathway, it was reported that there was a success rate of 82% after the first injection and relief from pain lasting, on average, for 6 months. In another recent study, Gonnade et al [20] prospectively examined 31 patients with chronic coccydynia on whom ganglion impar blockade had been carried out, and they evaluated their pain through the NRS and their functionality through the oswestry disability index (ODI) at 2, 4, 12, and 24 weeks [21]. The authors have reported a profound decrease in pain levels, a decrease in NRS scores, and noticeable positive results in the ODI [20].…”